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Abstract
Background: The main objective of this study was to demonstrate the effectiveness of daily measurements of liver enzymes along with c-reactive protein (CRP), and 
complete blood count (CBC) for the successful management of septic cases in neonates.
Method: A sample of septic neonates (48 individuals), along with 40 non-septic neonates, was randomly selected for the daily measurement of liver function tests 
(aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase (ALP)), blood culture, CRP, and CBC during the routine medical 
treatments of sepsis cases in neonates. The abovementioned parameters were measured according to international laboratory standards. Data were statistically analyzed 
to determine whether there were correlations among parameters. 
Results: The data showed elevated levels of white blood cells (WBCs), ALT, AST, ALP, and CRP and a reduced level of platelets on the first day of medical treatment 
(on admission). Daily measurement of the parameters provides a trend with the direction of medical treatment. Strong correlations were found between CRP and 
blood parameters. Successful medical treatment indicated a continuous reduction of WBCs, ALT, ALP, AST and CRP and increased level of platelets to reach the 
values of the reference range and/or the control group at the end point.
Conclusion: Daily measurements of ALT, AST, ALP and CRP along with blood counts are driving toward the successful diagnosis and management of septic cases 
in neonates. The implementation of these diagnostic parameters around the globe may reduce the morbidity and mortality in neonates. 
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Background
Sepsis and septic shocks are leading causes of mortality in neonates 
worldwide. It is well known in the literature that sepsis remains a major 
cause of morbidity and mortality for neonates in many countries around 
the globe. The early diagnosis of sepsis among neonates is an important 
step toward its successful management. Previous diagnostic efforts 
included performing a clinical chorioamnionitis [1], assessing the role of 
infection and noninfectious inflammation in epidural analgesia-related 
fever on the mother-neonate relationship [2], assessing the prevalence 
and diversity of microbes in the amniotic fluid [3], evaluating the role 
of innate host defenses in susceptibility to early-onset neonatal sepsis 
[4], evaluating the role of bacteria on early-onset neonatal sepsis [5], 
assessing the frequency of low level bacteremia in infants from birth to 
two months of age [6], and analyzing the blood culture [7]. 
Furthermore, many authors emphasized the diagnostic values of 
biochemical aspects such as cerebrospinal ﬂuid protein concentration 
in neonates [8-11], C-reactive protein in neonatal group B streptococcal 
infection [12,13], and serum 1,3β-d-glucan assay in the early diagnosis 
of invasive fungal infections in a neonatal intensive care unit [14]. 
Moreover, several researchers highlighted the diagnostic value 
of neonatal blood count [15], indexes of leukocyte and neutrophil 
concentrations [16], plasma ﬁbronectin level in sepsis screens in 
neonates [17], the value of thrombocytopenia [18], platelet count 
[19], and the value of serum procalcitonin [20]. A recent diagnosis 
[21] described the clinical future of severe sepsis signs and symptoms 
among neonates in Indonesia. 
It is obvious that diagnostic efforts include clinical signs and 
symptoms, neonate blood counts, blood culture, and few biochemical 
investigations. The limitations of the abovementioned reports are that 
they focused on analyzing one blood parameter that was not enough 
to provide a complete picture of the septic case and its complications. 
Moreover, the abovementioned reports did not kinetically measure 
CBC, blood biochemistry, or blood culture and did not find correlations 
among blood parameters. Additionally, these studies did not include the 
measurement of AST, ALT, and ALP (liver biomarkers) in the diagnosis 
of sepsis in neonates. Furthermore, the kinetics of WBCs, CRP, platelet 
levels, ALT, AST, and ALP levels in sepsis remain poorly investigated. 
This study was designed to demonstrate the effectiveness of daily 
measurements of liver enzymes along with CRP, and CBC for the 
successful management of septic cases in neonates and characterized 
the regression correlations among them during the medical treatment. 
Methods 
Neonate population size
Forty-eight neonates having at least three of the following signs 
and symptoms (hypothermia, hyperthermia, tachypnea, mild jaundice, 
cyanosis, hypoactive, or feeding, mild distress) Omran et al. [22] were 
randomly selected and included in the study. These cases were observed 
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for 6 months. Another forty neonates who did not have any of the signs 
mentioned above but were hepatized for physiological sickness and 
have no infection were also randomly chosen as the control group. 
The parents of the septic and the control groups were convinced to 
participate in the study, and they signed consent forms. The study was 
approved by the Ministry of Health and the Helsinki Committee for 
Human Rights. 
Blood collection
Following the procedure previously described [23], venous blood 
samples (2 mL) were collected from each patient into K3-EDTA 
tubes and serum vacutainer tubes. Complete blood counts (CBCs) 
were performed within 2–4 hours of collection using an autoanalyzer 
(Cell-Dyn 1800 Sapphire, Abbott Diagnostics). CBC included white 
blood cell count (WBC), red blood cell count (RBC), hemoglobin 
(Hb) concentration, and platelet count (PLT). The abovementioned 
parameters were measured every day to kinetically evaluate the 
movements of the parameters during the medical treatments.
Blood cultures 
Blood samples were collected from the sepsis cases and transferred 
to a special sterile bottle. The microbes were identified in the 
bacteriology unit in the central laboratory at the Ministry of Health in 
Gaza using the polymerase chain reaction method. 
Measurement of blood parameters
Determination of CRP: CRP levels were determined in the serum 
obtained from the septic cases only using a semiquantitative serological 
method according to Ministry of Health laboratory standards 2016. In 
this procedure, 50 µL of serum was mixed with 50 µL of CRP reagent 
(CRP Latex, Ref LXCRP005; LOT CL-1608-1/61; purchased from UK 
via an Israeli company) for 30 minutes. In case the CRP concentration 
was below 6 mg/dl, nothing was observed in the mixture, whereas at 
concentrations above 6 mg/dl, agglutination occurred. In this case, serial 
dilutions should be performed until we notice that no agglutination 
would occur. Then, CRP value would be calculated by multiplying the 
number 6 with dilution times during the measurements. In some cases, 
a concentration below 6 mg/dl was measured in a special laboratory. 
To date, CRP levels below 6 mg/dl have been considered to be negative 
according to the Ministry of Health [24]. 
Deamination of live enzymes: The serum was obtained from 
each blood sample by centrifugation at 3000 rpm for 15 min at 10 
°C. The obtained serum was used to determine the activity of liver 
function enzymes [aspartate aminotransferase (AST) and alanine 
aminotransferase (ALT) and alkaline phosphatase (ALP)] according to 
a previously developed method [25] using commercially supplied kits, 
ref. number 10441 99 10021, lot 60112654, purchased from DiaSys, 
Germany, through an Israeli company. AST and ALT activities were 
measured based on Reitman and Frrankel [26] using a commercially 
available kit for AST ref. numbers 126019910021, lot 60112076, and 
ALT kit ref. BXC0213D, lot 162254, from Bio-Merieux, purchased from 
an Israeli company. AST, ALT and ALP values were determined every 
day during the medical periods.
The percentage of enzyme activation was calculated according to 
equation 1, El-Nahhal et al. [27]
(EAT)%Relative Enzyme Activation =
(EAR)
                                  (1)
where EAT and EAR are the enzyme activity measured at a certain 
time in the sepsis cases and the enzyme activity of the control group 
(reference range), respectively.
Antibiotic microbial response tests
Dose response relationships were conducted in the hospital 
laboratory in accordance with the international method.
Management and medical follow-up of the cases
Three well-qualified medical teams from the main hospital in 
Gaza took care of the medical requirements and follow up of the cases 
according to the international methods. They observed the cases for 
24 h in accordance with well-known international medical standards. 
Statistical analysis
The septic cases were characterized into three groups according 
to the microbes that were detected. Individuals of each group were 
counted together. The means and standard deviations were calculated 
for each group during medical treatment in the intensive care unit. 
A t-test was used to detect a difference among means and to indicate 
whether a medical treatment for patient is still required or not. In the 
case of no significant differences were detected, this indicates that the 
patients were improved and can be released from the hospital.
AST0 /ASTt ratios were calculated and regressed vs medical 
treatment time, where AST0 and ASTt are the initial and the final value 
after treatment, respectively. Furthermore, CRP values were regressed 
vs. AST, ALT, WBC, and PLT.
Results
Blood culture and clinical signs 
Blood culture identified three microbial infections in the septic cases 
of the neonates. These microbes are E. Coli, Staphylococcus aureus and 
Klebsiella sp.; their infections in neonates are complicated and require 
careful attention during the medical follow-up period in the hospital. 
The clinical signs of the septic groups are shown in Table 1. It 
is obvious that each case has thermal instability (hyperthermia or 
hypothermia), tachypnea, mild jaundice or cyanosis, hypoactivity, poor 
Baby item S. aureus. E. coli Klebsiella Control group
Thermia Hypert Hypo Hypo Normal
Tachypnea √ √ √ -
Mild jaundice √ √ - √
Cyanosis - - √ -
hypoactive √ √ √ -
Feeding mode NGT NGT NGT Normal
poor feeding √ √ √ -
respiration - Mild distress Mild distress - 
blood culture + + + -
patients 19 15 14 40 
Female 10 (52.6) 9 (60) 7 (50) 23 (57.5)
Male 9 (47.4) 6 (40) 7 (50) 17 (42.5)
Gestational
age range 
(weeks)
34-36 34-36 34-36 38
Birth weight 2.15-2.85 2.75-3.15 2.70-3.16 3.1-3.76
Temperature 
range 36-39 36-39 36-39 36.8-37.4
Table 1. Blood culture and clinical symptoms 
NGT: Nasogastric tube.
Values in brackets indicate % of the case under investigation.
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feeding and mild respiratory distress. These clinical signs are common 
in neonate septic cases. 
Blood parameters
The kinetic measurements of blood parameters such as hemoglobin 
(HB), white blood cells (WBCs) and platelets (PLT) of forty septic cases 
in neonates are presented in Table 2. It can be seen that HB values are 
not significantly changed in the sepsis cases during the medical period 
in the intensive care unit. This indicates that HB is not directly involved 
in the complication of sepsis cases. However, it can be observed that 
WBC values are high on the 1st day (on admission) and slowly decline 
during the medical treatment, becoming close to the value in the control 
group on the last day of medical treatments (8th day). Moreover, the 
trend of WBCs is similar in the three microbial infections. Statistical 
analysis did not detect a significant difference in WBC values in the 
three microbial infections; however, significant differences were found 
in comparison with the same parameters in the control group. 
In contrast, platelet values were the lowest on the 1st day (on 
admission) and increased gradually to be the highest on the last day of 
medical treatment. The trend is similar in the other microbial infection 
groups. Statistical analysis did not detect significant differences among 
microbial infection groups, whereas significant differences were found 
with the control group. Moreover, it is obvious that the medical period 
of each microbial infection was 8 days; in some cases, the medical 
period reached 11 days, but those were excluded from the study.
Additionally, CRP values were at the highest value (24 mg/dl) on 
the first day of medical treatment; then, the value declined and was 
below 6 mg/dl on the 8th day in all sepsis patients. However, CRP values 
remained at a high level on the 1st and 2nd days in the sepsis cases that 
were caused by E. Coli and Staphylococcus aureus during the medical 
treatment periods (Table 2). CRP was high during the maximum 
infection and declined below 6 mg/dl, the normal range according to 
the standards of the Ministry of Health [24], due to medical treatments. 
Statistical analysis did not identify a significant difference.
However, CRP values are similar in all septic cases in neonates. 
The similarities of the values are a result of the measurement methods 
(qualitative descriptive method).
Liver biomarkers
Liver biomarkers of septic cases caused by E. Coli, Staphylococcus, 
Klebsiella and the control group are presented in Table 3.
Generally, ALT, AST and ALP values are higher on the first day of 
hospital admission (1st day) than on the last day of medical treatment. 
This trend is similar in the three microbial infections in sepsis cases. 
However, ALT values on the 1st day were higher in E. coli sepsis cases 
than in others. Statistical analysis detected significant differences. This 
suggests that E. coli caused liver damage more than the other types of 
sepsis. During medical treatment, ALT values of E. coli remained higher 
than those of other cases in the same day, suggesting complications of 
E. coli. Then, the levels tend to slow down to reach the normal range on 
the 8th day of medical treatments. 
The medical team gave the sepsis cases bacteria-sensitive antibiotics 
during the medical period. The decline in ALT, AST and ALP values 
during the medical period indicated the suppression and/or reduction 
of the microbial population. This is a leading step toward the successful 
management of sepsis. Comparison of liver enzymes among the three 
sepsis groups shows that E.coli raised liver biomarkers higher than 
Staphylococcus aureus and Klebsiella. This suggests that E. coli led to 
more complications in neonates. Accordingly, septic cases caused by 
E. coli required a longer treatment period than septic cases caused by 
Staphylococcus aureus or Klebsiella. To date, Staphylococcus aureus 
appeared to cause less effects on liver enzymes than did the others.
Correlations among blood parameters
Correlations between CRP/AST, ALP, and ALT are presented in 
Figure 1, and correlations between CRP and HB and WBC and PLT 
in sepsis cases with E. coli and Staphylococcus aureus are presented in 
Figure 2. It is clear that CRP/PLT correlation is strongly negative with 
an exponential mode, whereas the other correlations are strongly posi-
tive with an exponential mode. This suggests that the microbes have a 
similar mode of infection. We also concluded the correlations between 
relative elevations of enzyme vs time, as shown in Figure 3. 
Biomarker
E. coli
1st day 2nd day 3rd day 4th day 5th day 6th day 7th day 8th day 
HB a18.00±1.00 a17.20±0.69 a17.87±1.15 a17.47±0.35 a17.40±1.01 a16.83±1.04 a15.33±1.61 a15.47±1.10
WBCs ab31.67±10.41 ab29.83±9.44 ab30.03±8.60 ab26.83±7.49 ab22.03±5.49 ab15.67±2.03 ab13.90±3.61 ab13.17±2.47
Platelets ac72.00±24.33 ac89.00±36.76 ac95.00±26.46 ac97.00±42.04 ac121.33±44.61 ac148.33±52.52 ac216.67±70.24 ac228.67±65.58
CRP d24.00±0.0 d24.00±0.0 d16.00±6.93 d14.67±8.33 d8.00±3.46 d6.33±5.01 d2.50±1.5 d2.00±1.0
Staphylococcus aureus
 1st day 2nd day 3rd day 4th day 5th day 6th day 7th day 8th day
HB a18.33±1.53 a17.30±0.85 a17.83±1.65 a17.17±0.81 a16.67±0.29 a17.17±0.58 a17.00±1.41 a16.55±2.90
WBCs ab32.67±12.70 ab29.00±11.27 ab24.33±9.50 ab24.60±8.62 ab19.67±5.50 abc20.00±2.65 ac17.50±3.54 ab14.75±3.89
PLT ac73.33±20.82 ac90.00±5.00 ac107.33±21.94 ac119.00±24.56 ac173.33±46.19 ac190.00±57.66 ad175.00±35.36 ac325.00±21.21
CRP d24.00±0.00 d20.00±6.93 d10.00±3.46 d8.00±3.46 d5.33±1.15 d4.33±1.76 d2.67±1.76 d1.67±0.76
Klebsiella 
HB a16.85±0.49 a17.00±1.13 a16.65±0.21 a16.60±0.85 a16.45±0.35 a16.35±0.21 a16.35±0.21 a16.50±0.99
WBCs ab32.50±10.61 ab29.85±10.39 ab26.00±9.19 ab23.10±8.34 ab22.70±8.20 Abc19.35±4.45 ac16.05±4.45 ab13.50±2.47
PLT ac92±14.14 ac95±7.07 ac105±2.12 ac135±4.95 ac145±5.66 ac160±17.68 ac180±10.61 ac190±3.54
CRP a24.00±00 e12.00±00 d12.00±00 d6.00±00 dd6.00±00 d4.50±0.71 d3.25±0.35 d2.25±0.30
Control group
HB a16.5± 2.51 a17.5±2.67 a14.5± 3.45 a15.3± 3.21 a15.95±1.97 a16.5±1.87 a17.5±2.86 a14.5±0.58
WBC ac11.2± 3.21 ac11.2±3.53 ac12.1± 2.56 ac12.7± 1.76 ac11.8±1.85 abd11.2±2.45 ab11.2±2.35 ab12.1±1.78
PLT ad210±15.72 ad250±19.24 ad310±22.51 ad290±20.76 ad265±18.35 ad240± 11.98 ac250±10.52 ac300±25.5
Table 2. Blood biomarker in neonate septic cases affected by E. coli and Staphylococcus aureus. Values (mean±SD) that have the same letter/s in the same column (day) are not 
significantly different at p-value=0.05
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Biomarker
E. coli
1st day 2nd day 3rd day 4th day 5th day 6th day 7th day 8th day
ALT a73.33±14.74 a57.33±6.43 a58.33±3.51 a56.00±5.20 a58.33±15.37 a46.00±5.29 a43.00±5.29 a38.00±1.00
AST ab69.00±9.64 ab57.00±1.73 ab55.67±8.02 ab56.33±10.21 ab58.33±11.85 ab49.67±0.58 ab42.33±5.13 ab37.00±4.34
ALP ac250.00±50.00 ac236.67±55.08 ac230.00±43.59 ac223.33±40.41 ac235.00±25.98 ac190.00±36.06 ac186.67±15.28 ac166.67±15.28
 Staphylococcus aureus
 1st day 2nd day 3rd day 4th day 5th day 6th day 7th day 8th day
ALT b60.0±4.5 a55.00±7.0 b50.00±5.0 b47.33±5.03 a47.00±6.08 a43.67±10.41 a41.33±4.73 a39.00±4.24
AST ab60.0±10.00 ab55.67±12.10 ab52.67±10.69 ab53.67+13.65 ab51.00±13.89 ab48.33±9.50 ab50.00±7.07 ab41.50±4.95
ALP ac233.33±28.87 ac206.67±5.77 ac207.33±6.43 ac203.33±15.28 ac205.00±5.00 ac201.67±7.64 ac200.00±10.00 ac181.67±2.89
 Klebsiella 
ALT c56.00±5.66 a53.50±12.02 a53.50±16.26 c48.00±14.14 a43.50±12.02 a40.00±11.31 a37.50±10.61 a35.50±9.19
AST ab56.50±2.12 ab54.50±7.78 ab53.50±12.02 ab47.50±10.61 ab44.50±9.19 ab42.00±9.90 ab39.00±7.78 ab39.50±8.49
ALP aa200.00±0.00 ac200.00±11.12 ac200.00±14.14 ac200.00±7.5 ac200.00±9.14 ac210.00±10.61 ac217.50±21.21 ac215.00±12.14
Control group
ALT c39.0±12.21 b32± 3.42 c 42±3,77 b41±5.93 a42±5.48 a45±5.92 a40±3.95 a43±5.43
AST ac41± 9.83 ac39±5.61 ac45±2.93 ac38±8.75 ab46±7.57 ab46±8.33 ab40±4.76 ab43±8.26
ALP ad185± 5.33 ad175±5.36 ad175±4.32 ad170±9.85 ad182±8.96 ac178±12.74 ac204±15.84 ac183±13.92
Table 3. Liver biomarker in neonate septic cases affected by E. Coli and Staphylococcus aureus. Values (mean ±SD) in a column that have same letters are not significantly different at 
p-value = 0.05
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Figure 1. Correlations between CRP and ALT, AST and ALP in septic cases with E. coli and Staphylococcus aureus. Error bars represent the standard deviation
Discussion 
The main objective of this study was to demonstrate the effectiveness 
of daily measurements of liver enzymes along with CRP, and CBC for 
the successful management of septic cases in neonates.
Our data show the effective use of several parameters such as 
blood culture, blood counts (HG, WBC, and PLT), CRP, ALT, AST 
and ALP and the statistical correlations among these parameters. 
The data in Table 1 clearly show the clinical signs of neonatal septic 
cases. These signs are in agreement with the septic signs characterized 
by Omran et al. [22], who revealed that the clinical findings of sepsis 
included the presence of three or more of the following: (1) temperature 
instability (hypothermia or hyperthermia); (2) respiratory alterations 
(grunting, intercostal retractions, apnea, tachypnea, or cyanosis); (3) 
cardiovascular alterations (bradycardia, tachycardia, poor perfusion, 
or hypotension); (4) neurologic alterations (hypotonia, lethargy, or 
seizures); and (5) gastrointestinal alterations (feeding intolerance).
The blood culture indicated the presence of E. coli, Staphylococcus 
aureus, and Klebsiella sp. in the blood of the neonates. This indicates 
the possibility of multi-organ infection. As a result of this microbial 
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Figure 2. Correlations between CRP and HB and WBC and PLT in sepsis cases with E. coli and Staphylococcus aureus. Error bars represent the standard error
infection, the author scores seven biomarkers to assess their adequacy 
in being cumulative diagnostic parameters associated with sepsis in 
neonates. These parameters are positive blood culture microbe test, 
WBC and platelet counts, concentrations of CRP, and activity of each 
enzyme, i.e., ALT, AST, and ALP. These parameters have high value in 
this study.
For instance, an elevated level of the WBC count indicated an 
infection with microbes. This is evidence from the results of blood 
culture and in accordance with Díaz et al. [28], who analyzed the 
usefulness of WBC count along with other blood parameters for the 
diagnosis of invasive bacterial infections and revealed the importance 
of WBC along with other blood parameters to confirm or dismiss the 
presence of invasive bacterial infections in infants. A similar observation 
was found by Zarkesh et al. [29], who emphasized the diagnostic value 
of WBC count, along with other blood parameters, to predict serious 
bacterial infections in febrile infants. Furthermore, the data in Table 2 
clearly show a lower value of platelets on the 1st day of medical treatment 
compared with the other days. Then, the platelet level tends to increase 
and become closer to the normal range. Our results agree with those 
of Zhao et al. [30], who found platelet count (PC), plateletcrit (PCT), 
and platelet distribution width values were significantly lower in the 
invasive fungal disease versus preterm control infants. The explanation 
of these results is that E. coli, Staphylococcus aureus or Klebsiella sp. 
may interact with the platelets, resulting in the destruction of cells; 
consequently, a reduced level was observed in the neonatal septic cases. 
Our explanation agrees with that of Martini et al. [31], who studied 
the bacterial contamination index in platelet concentrates obtained 
from the blood center of the State of Rio Grande do Sul (HEMORGS) 
and found that two Staphylococcus sp. were associated with platelet 
analysis. Furthermore, Siauw et al. [32] provided evidence of the direct 
involvement of platelets in the pathogenesis of inflammation and 
sepsis. The same authors revealed that several bacteria are known to 
directly interact with platelets, leading to activation and aggregation, a 
phenomenon also observed with infection with group B Streptococcus. 
Thus, considering platelet level as a biomarker for neonatal sepsis is in 
accordance with Zhao et al. [30], who revealed that platelet parameters 
could be useful biomarkers for the diagnosis and prognosis of neonatal 
invasive fungal disease. During medical treatment, a reduction in the 
microbial population might have occurred, resulting in increasing 
platelet levels.
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Furthermore, CRP values were higher on the 1st day of medical 
treatment than the last day of medical treatment (Table 2). To date, CRP 
is a widely used marker of inflammation. It is synthesized by liver cells 
in response to pro-inflammatory cytokines as described by Marnell 
et al. [33]. Concentrations of CRP in blood are very low in healthy 
individuals (control group) but may rapidly increase after induction of 
an inflammatory response that is associated with microbial infections, 
as seen in this study. CRP has been considered a useful biomarker for 
many diseases such as human lung epithelial cells [34], oxidative stress 
[35], septic shocks [36] and neonatal sepsis [37].
The data in Table 3 clearly demonstrate elevated levels of liver 
biomarkers. Our results agree with Yuzurihara et al. [38], who found 
elevated liver enzymes (ALT and  AST) in 16 patients had bilirubin 
measurements above 3 mg/dl. Similar results were found with acute 
poisoning [39,40]. The elevation of liver enzymes indicates oxidative 
stress in the liver of the neonates. This can be explained by the fact 
that the microbes, E. coli, Staphylococcus aureus, and Klebsiella, dis-
charged their toxins in the blood of the neonates. These toxins reached 
the liver and were exposed to metabolic and detoxification processes. 
This resulted in the elevation of liver biomarkers (ALT, AST, and ALP) 
as shown in Table 3. Our explanation is in accordance with Becker et 
al. [41], who demonstrated that S. aureus toxin (α-toxin) induced an 
activation of the acid sphingomyelinase and a concomitant release of 
ceramide in endothelial cells treated with the toxin. Furthermore, a 
similar observation was found by Bakker et al. [42], who revealed an 
elevation of serum alanine transaminase concentration of more than 
twice the upper limit in severe septic cases. In a different observation, 
Angus et al. [43] found hepatic failure in severe sepsis cases in seven 
states in the US. Furthermore, the presented results are consistent with 
those of Ma et al. [44], who described a novel mechanism of how S. 
aureus α-toxin triggers activation of the acid sphingomyelinase and a 
release of ceramides, resulting in the release of lysosomal cathepsin B 
and the formation of pro-inflammatory cytokines. 
As a result of the medical treatment, the growth of microbes is 
reduced or suppressed; thus, the amount of toxins that are produced 
and discharged in the blood is reduced. Liver biomarkers tended to 
slow down and became very close to the border line of the normal 
range at the end of medical treatment. The elevation of liver biomarkers 
was associated with high values of CRP. This observation agrees with 
previous reports [14,35] that found oxidative stress to be associated 
with high values of CRP. 
The data in Figure 2 clearly demonstrate a strong negative 
association between CRP/PLT and a strong positive association with 
ATL and WBCs of E. coli and Staphylococcus aureus septic cases in 
neonates. Similar observations were found with Klebsiella (data not 
shown). The relationships in both cases have exponential modes, and 
the R2 values were in the range of 0.8412-0.9387. These relationships 
suggest that the microbes or their toxins attack the blood system as 
shown by the decreased levels of platelets mentioned above (Table 1). 
Our suggestion agrees with Mitsiakos et al. 45, who investigated the 
significance of platelet (PLT) count and platelet mass (PM) in promptly 
predicting neonatal intracranial hemorrhage (ICH); the results revealed 
that the median PLT count and PM at days 1, 2, and 3 after diagnosis 
of gram-negative sepsis was significantly associated with the presence 
of ICH. A similar observation was also obtained with Zhao et al. [30], 
who revealed the importance of the platelet parameter as a useful 
biomarker for the diagnosis of neonatal sepsis. Moreover, the data in 
Figure 3 clearly demonstrate the relative increase of AST as affected by 
the type of microbe. It is obvious that E. coli created the highest relative 
elevation of AST compared with other types of microbes. These data 
suggest severe damage or impairment of hepatic cells that results in 
AST leakage in the blood serum. This result agrees with El-Nahhal [46], 
who revealed an increased AST to ALT ratio because of toxic effects of 
zinc phosphide in humans.
Statistical analysis of the sepsis cases and control group that was 
generated every day (presented in Tables 2 and 3) showed significant 
differences during the days of medical periods; however, on the last day 
of medical treatment, no significant differences were detected. From the 
medical point of view, significant differences indicate that additional 
medical treatment is required for sepsis cases; in contrast, no significant 
differences indicate that no medical treatment is required for sepsis and 
that the patient can be released from the hospital. 
Comparison between our results and those in the literature
A comparison between the present study and those from the 
literature is presented in Table 4. It is obvious that the present study 
kinetically measured seven parameters of great importance for the 
diagnosis of septic cases among neonates. Furthermore, it dealt with 
11 scientific elements to provide concrete biomarkers for the successful 
diagnosis and management of sepsis, whereas other studies [12,22-
29,31] did not measure AST, ALT and/or ALP; they measured a few 
biomarkers such as clinical signs, blood culture, HG, WBC, PLT and 
CRP. The weakness of the mentioned reports is that they did not 
kinetically measure the biomarkers of their concern. The presented 
study provided kinetic data on the importance of HG, WBC, PLT, CRP, 
AST, ALT, and ALP. Previous studies by Omran et al. [22], Díaz et al. 
[28], Zarkesh et al. [29], and Ellahony et al. [37] provided valuable 
data on the diagnosis of sepsis in neonates, but they dealt with few 
biomarkers compared with this study. It can be concluded that the 
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present study integrated the results by employing several biomarkers 
for the successful diagnosis and management of sepsis in neonates. 
This study highlights the importance of kinetic measurements and 
brings hope for better medical care and the reduction of morbidity and 
mortality in neonates. 
Conclusion
The rationale of this work emerged from the fact that these seven 
parameters are, for the first time, being cumulatively measured in 
the septic cases as a successful diagnostic tool leading to successful 
management of the cases. Thus, the successful application of new 
biomarkers is based on a blood culture to identify the microbes, 
followed by complete blood count, CRP, ALT, AST and ALP 
measurements. For the successful management of the septic cases in 
neonates, it is necessary to kinetically measure all parameters except 
the blood culture. At the minimum, it is strongly recommended to 
kinetically measure CRP values during the medical period. In general, 
blood culture identification, WBC, platelets, liver biomarkers and 
CRP are the driving parameters in the successful diagnosis of a septic 
case. 
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